Cardiovascular Systems Inc. announced the first use of its Diamondback 360, 60cm Peripheral Orbital Atherectomy System for the treatment of peripheral artery disease.
CSI’s new system offers more treatment options for lesions in the lower leg by providing a low-profile system that is compatible with alternative access sites in the foot or ankle, according to Jihad A. Mustapha, MD, director of Heart and Vascular at Metro Health Hospital, Wyoming, Mich., and the first to use the system.
“Many of the patients we treat have advanced PAD [peripheral artery disease] and suffer from critical limb ischemia,” he said in a press release. “Having a variety of treatment options allows us to treat a broader range of patients who may otherwise be facing amputation.”
The OAS uses a combination of differential sanding and centrifugal force to reduce arterial plaque, including calcium, which can cause complications when treating PAD.
More than 12 million Americans suffer from PAD, commonly in the pelvis or the leg. “If left untreated, these cases may result in lower limb amputation,” David L. Martin, chief executive officer and president of CSI, said in the release. “Our new devices have been shown to reduce procedure times and decrease complications, enabling quicker recovery.”